Value investing remains one of the most proven strategies for long-term wealth creation. As the Indian market enters a consolidation phase after the 2025 rally, several blue-chip stocks are now trading at attractive valuations. Here are five undervalued large-cap stocks that offer compelling risk-reward for patient investors.
1. ITC Limited (NSE: ITC)
Current Price: Rs 435 | Target: Rs 580 | Upside: 33%
ITC continues its transformation from a tobacco-dependent company to a diversified FMCG powerhouse. The company’s FMCG segment revenue has grown at 18% CAGR over the last five years, and its hotels business is firing on all cylinders post-demerger announcement.
- P/E ratio at 24x, below 5-year average of 28x
- Dividend yield of 3.2% provides downside protection
- FMCG margins expanding quarter-on-quarter
2. State Bank of India (NSE: SBIN)
Current Price: Rs 780 | Target: Rs 1,050 | Upside: 35%
SBI is trading at just 1.4x book value despite delivering ROE above 16% for three consecutive quarters. The bank’s asset quality continues to improve with GNPA ratio dropping to 2.1%, the lowest in a decade.
- Credit growth of 15.8% YoY outpacing industry average
- NIM stable at 3.3% despite rate cycle concerns
- Subsidiaries (SBI Life, SBI Cards) unlocking value
3. Larsen & Toubro (NSE: LT)
Current Price: Rs 3,420 | Target: Rs 4,500 | Upside: 32%
L&T sits at the epicentre of India’s infrastructure boom. With an order book exceeding Rs 5 lakh crore, the company has unparalleled revenue visibility. Government spending on roads, railways, and defense provides a multi-year growth runway.
4. Sun Pharmaceutical (NSE: SUNPHARMA)
Current Price: Rs 1,680 | Target: Rs 2,200 | Upside: 31%
Sun Pharma’s specialty portfolio, led by Ilumya and Winlevi, is scaling rapidly in the US market. The company’s EBITDA margin has expanded to 28%, and its pipeline of complex generics and biosimilars offers significant growth optionality.
5. Hindustan Unilever (NSE: HINDUNILVR)
Current Price: Rs 2,350 | Target: Rs 2,900 | Upside: 23%
HUL has underperformed the broader market by 20% over the past year, creating an attractive entry point. Rural demand recovery, premiumization trends, and margin expansion from benign commodity prices are expected to drive re-rating.
Investment Strategy
For investors looking to build a long-term portfolio, a staggered approach works best. Consider investing in three tranches over the next 3-6 months to average out any near-term volatility. These stocks combine quality management, strong balance sheets, and growth visibility.
Disclaimer: This article is for educational purposes only and should not be considered as investment advice. Please consult your financial advisor before making investment decisions.
